| Title |
Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions
|
|---|---|
| Published in |
Investigational New Drugs, January 2005
|
| DOI | 10.1023/b:drug.0000047101.02178.07 |
| Pubmed ID | |
| Authors |
Ephraim P. Lansky, Wenguo Jiang, Huanbiao Mo, Lou Bravo, Paul Froom, Weiping Yu, Neil M. Harris, Ishak Neeman, Moray J. Campbell |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | 1% |
| China | 1 | 1% |
| Unknown | 86 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 17 | 19% |
| Student > Bachelor | 15 | 17% |
| Researcher | 12 | 14% |
| Student > Master | 12 | 14% |
| Professor > Associate Professor | 7 | 8% |
| Other | 9 | 10% |
| Unknown | 16 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 24 | 27% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 13% |
| Biochemistry, Genetics and Molecular Biology | 6 | 7% |
| Nursing and Health Professions | 5 | 6% |
| Medicine and Dentistry | 5 | 6% |
| Other | 17 | 19% |
| Unknown | 20 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 46. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2023.
All research outputs
#909,069
of 25,374,917 outputs
Outputs from Investigational New Drugs
#14
of 1,262 outputs
Outputs of similar age
#1,659
of 151,229 outputs
Outputs of similar age from Investigational New Drugs
#1
of 13 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,262 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 151,229 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.